Purchase Order 36C24626P0438

The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 6 (VISN 6), awarded a firm fixed-price purchase order valued at $49,748.73 to Novocure Inc. for an implant product, with an ultimate completion date of March 27, 2026. The contract, which was awarded on February 27, 2026, carries no set-aside designation and will be performed in Portsmouth, New Hampshire. Novocure Inc., a foreign-owned medical device manufacturer specializing in innovative cancer treatment technologies, serves as the prime contractor with no subcontractor involvement.

This purchase order falls under Novocure's existing Federal Supply Schedule contract (FSS-65-II-A) for Medical Equipment and Supplies with the VA Veterans Health Administration, valued at $28.85 million through October 31, 2027. Novocure's primary offering is the Optune system, which utilizes Tumor Treating Fields (TTFields) technology for treating solid tumor cancers, including FDA-approved applications for glioblastoma and mesothelioma. The company functions as the sole source provider of these specialized cancer treatment systems to the VA, delivering Optune Plus transducers, medical device systems, and associated support services to VA medical centers nationwide. This award represents one of over 100 individual delivery orders and purchase orders issued to Novocure under the FSS contract vehicle, reflecting the VA's strategic commitment to expanding veterans' access to non-invasive oncology treatment options across its integrated service network.